Carolyn Metivier, APRN
Nurse Practitioner · Boston, MANPI 1669613337
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $81,033 of the $92,968 with a category attached, or 87.2%. 21 manufacturers reported payments, led by AbbVie at 53.1% of the total. Reporting peaked in 2021 at $51,312 and has fallen 99.9% since, to $44 in 2025. Among nurse practitioner clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 268 payments — averaging $346.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$49K
- Lundbeck LLC$18K
- Biohaven Pharmaceuticals, Inc.$16K
- Biohaven Pharmaceutical Holding Company Ltd.$7K
- Medtronic$1K
- Teva Pharmaceuticals USA, Inc.$137
- plus $480 from 15 others
What the payments were for
- Consulting fees$2,2632%
- Speaking & faculty fees$81,03387%
- Travel & lodging$4,4845%
- Food & beverage$5,1095%
- Education$810%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 83 | $49,373 |
| Lundbeck LLC | 49 | $18,351 |
| Biohaven Pharmaceuticals, Inc. | 55 | $16,408 |
| Biohaven Pharmaceutical Holding Company Ltd. | 31 | $7,110 |
| Medtronic | 16 | $1,110 |
| Teva Pharmaceuticals USA, Inc. | 6 | $137 |
| Sunovion Pharmaceuticals Inc. | 6 | $103 |
| AstraZeneca | 3 | $49 |
| Kyowa Kirin, Inc. | 3 | $47 |
| MDD US Operations, LLC | 2 | $40 |
| Xeris Pharmaceuticals, Inc. | 2 | $36 |
| Biogen | 2 | $35 |
| Amgen | 2 | $30 |
| Adamas Pharmaceuticals, Inc. | 1 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
| Acorda Therapeutics, Inc | 1 | $20 |
| Abbott | 1 | $17 |
| Eisai Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $16 |
| Neurocrine Biosciences, Inc. | 1 | $14 |
| Novartis | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$31,048
- NURTEC ODT$22,380
- BOTOX$18,112
- VYEPTI$17,476
- QULIPTA$1,173
- SYNCHROMEDII$821
- VRAYLAR$670
How this compares
$92,968 in reported general payments places this provider in the 95th percentile of 3,855 nurse practitioner providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 126 | $2,108 |
| Buprenorphine | 14 | $1,639 |
| Pregabalin | 49 | $1,192 |
| Baclofen | 33 | $959 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 24 | $765 |
| Morphine Sulfate ErMorphine Sulfate | 20 | $758 |
| Morphine Sulfate | 35 | $722 |
| Gabapentin | 53 | $720 |
| Hydromorphone Hcl | 37 | $629 |
| Methadone Hcl | 25 | $454 |
| Tramadol Hcl | 25 | $385 |
| Tizanidine Hcl | 28 | $357 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $247 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Boston
- Teresa FogarenBoston$102K
- Miu Lai NgBoston$33K
- Lauren BurkeBoston$26K
- Ashley HilmesBoston$24K
- Kristina SkarbinskiBoston$24K
- Hilary UgrasBoston$19K
- Colleen TigheBoston$17K
- Stephanie McDonaldBoston$17K
- Alichia PatonBoston$12K
- Reava KhristenkoBoston$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.